Xylem (XYL) Liabilities and Shareholders Equity (2010 - 2026)

Xylem's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $17.0 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 2.39% year-over-year to $17.0 billion; the TTM figure through Mar 2026 stood at $69.1 billion (up 6.49% YoY), while the FY2025 annual figure was $17.6 billion, up 6.92% from the prior year.
• Liabilities and Shareholders Equity was $17.0 billion for Q1 2026 at Xylem, down from $17.6 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $17.6 billion in Q4 2025 to a low of $7.9 billion in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $14.0 billion across 5 years, with a median of $16.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity fell 6.78% in 2022, then jumped 102.62% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $8.0 billion in 2022, then soared by 102.62% to $16.1 billion in 2023, then grew by 2.36% to $16.5 billion in 2024, then increased by 6.92% to $17.6 billion in 2025, then fell by 3.86% to $17.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $17.0 billion (Q1 2026), $17.6 billion (Q4 2025), and $17.3 billion (Q3 2025), per Business Quant data.